Compare ICUI & NVST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ICUI | NVST |
|---|---|---|
| Founded | 1984 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9B | 4.1B |
| IPO Year | 1995 | 2019 |
| Metric | ICUI | NVST |
|---|---|---|
| Price | $125.37 | $24.31 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 12 |
| Target Price | ★ $182.25 | $25.33 |
| AVG Volume (30 Days) | 238.1K | ★ 2.1M |
| Earning Date | 05-07-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 100.62 | ★ 104.31 |
| EPS | 0.03 | ★ 0.28 |
| Revenue | $2,231,262,000.00 | ★ $2,566,500,000.00 |
| Revenue This Year | N/A | $6.67 |
| Revenue Next Year | $4.46 | $3.55 |
| P/E Ratio | $4,135.83 | ★ $87.84 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $107.02 | $14.22 |
| 52 Week High | $160.29 | $30.42 |
| Indicator | ICUI | NVST |
|---|---|---|
| Relative Strength Index (RSI) | 37.07 | 37.25 |
| Support Level | $122.17 | $24.24 |
| Resistance Level | $125.00 | $25.41 |
| Average True Range (ATR) | 4.84 | 0.96 |
| MACD | 0.15 | -0.17 |
| Stochastic Oscillator | 15.61 | 3.41 |
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.
Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments; Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment, which derives key revenue, develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. Geographically, the company generates a majority of its revenue from North America, followed by Western Europe and other developed and emerging markets.